{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T04:03:13Z","timestamp":1778299393380,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1038\/sj.bjc.6601072","type":"journal-article","created":{"date-parts":[[2003,7,15]],"date-time":"2003-07-15T17:14:20Z","timestamp":1058289260000},"page":"258-261","source":"Crossref","is-referenced-by-count":27,"title":["Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid"],"prefix":"10.1038","volume":"89","author":[{"given":"J A","family":"Christian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G J R","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Harmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,7,15]]},"reference":[{"key":"BF6601072_CR1","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/00003072-198510000-00011","volume":"10","author":"H Abdel-Nabi","year":"1985","unstructured":"Abdel-Nabi H, Hinkle GH, Falko JM, Kelly D, Olsen JO, Martin Jr. EW (1985) Iodine-131 labeled anti-CEA antibodies uptake by Hurthle cell carcinoma. Clin Nucl Med 10: 713\u2013715","journal-title":"Clin Nucl Med"},{"key":"BF6601072_CR2","first-page":"65","volume":"190","author":"GI Bell","year":"1995","unstructured":"Bell GI, Yasuda K, Kong H, Law SF, Raynor K, Reisine T (1995) Molecular biology of somatostatin receptors. Ciba Found Symp 190: 65\u201379","journal-title":"Ciba Found Symp"},{"key":"BF6601072_CR3","first-page":"89","volume":"190","author":"C Bruns","year":"1995","unstructured":"Bruns C, Weckbecker G, Raulf F, Lubbert H, Hoyer D (1995) Characterization of somatostatin receptor subtypes. Ciba Found Symp 190: 89\u2013101","journal-title":"Ciba Found Symp"},{"key":"BF6601072_CR4","first-page":"636","volume":"41","author":"EB Forssell-Aronsson","year":"2000","unstructured":"Forssell-Aronsson EB, Nilsson O, Bejegard SA, Kolby L, Bernhardt P, Molne J, Hashemi SH, Wangberg B, Tisell LE, Ahlman H (2000) 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors. J Nucl Med 41: 636\u2013642","journal-title":"J Nucl Med"},{"key":"BF6601072_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-0038-1632183","volume":"38","author":"R Gorges","year":"1999","unstructured":"Gorges R, Kahaly G, Muller-Brand J, Macke H, Walgenbach S, Bruns C, Andreas J, Brandt-Mainz K, Bockisch A (1999) Somatostatin receptor status in non-medullary thyroid carcinoma. Nuklearmedizin 38: 15\u201323","journal-title":"Nuklearmedizin"},{"key":"BF6601072_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/107327489700400101","volume":"4","author":"RF Grossman","year":"1997","unstructured":"Grossman RF, Clark OH (1997) Hurthle cell carcinoma. Cancer Control 4: 13\u201317","journal-title":"Cancer Control"},{"key":"BF6601072_CR7","first-page":"243","volume":"39","author":"SA Gulec","year":"1998","unstructured":"Gulec SA, Serafini AN, Sridhar KS, Peker KR, Gupta A, Goodwin WJ, Sfakianakis GN, Moffat FL (1998) Somatostatin receptor expression in Hurthle cell cancer of the thyroid. J Nucl Med 39: 243\u2013245","journal-title":"J Nucl Med"},{"key":"BF6601072_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF03351041","volume":"24","author":"LM Haslinghuis","year":"2001","unstructured":"Haslinghuis LM, Krenning EP, De Herder WW, Reijs AE, Kwekkeboom DJ (2001) Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer. J Endocrinol Invest 24: 415\u2013422","journal-title":"J Endocrinol Invest"},{"key":"BF6601072_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-59587-5_1","volume":"153","author":"EP Krenning","year":"2000","unstructured":"Krenning EP, Valkema R, Kooij PP, Breeman WA, Bakker WH, de Herder WW, van Eijck CH, Kwekkeboom DJ, de Jong M, Jamar F, Pauwels S (2000) The role of radioactive somatostatin and its analogues in the control of tumor growth. Recent Results Cancer Res 153: 1\u201313","journal-title":"Recent Results Cancer Res"},{"key":"BF6601072_CR10","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.1016\/S0021-9258(18)82045-2","volume":"268","author":"SF Law","year":"1993","unstructured":"Law SF, Yasuda K, Bell GI, Reisine T (1993) Gi alpha 3 and G(o) alpha selectively associate with the cloned somatostatin receptor subtype SSTR2. J Biol Chem 268: 10721\u201310727","journal-title":"J Biol Chem"},{"key":"BF6601072_CR11","first-page":"28","volume":"42","author":"S Rens-Domiano","year":"1992","unstructured":"Rens-Domiano S, Law SF, Yamada Y, Seino S, Bell GI, Reisine T (1992) Pharmacological properties of two cloned somatostatin receptors. Mol Pharmacol 42: 28\u201334","journal-title":"Mol Pharmacol"},{"key":"BF6601072_CR12","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1210\/jcem-56-6-1131","volume":"56","author":"NA Samaan","year":"1983","unstructured":"Samaan NA, Maheshwari YK, Nader S, Hill Jr CS, Schultz PN, Haynie TP, Hickey RC, Clark RL, Goepfert H, Ibanez ML, Litton CE (1983) Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab 56: 1131\u20131138","journal-title":"J Clin Endocrinol Metab"},{"key":"BF6601072_CR13","first-page":"598","volume":"37","author":"M Schlumberger","year":"1996","unstructured":"Schlumberger M, Challeton C, De Vathaire F, Travagli JP, Gardet P, Lumbroso JD, Francese C, Fontaine F, Ricard M, Parmentier C (1996) Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 37: 598\u2013605","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"BF6601072_CR14","first-page":"102","volume":"85","author":"SC Short","year":"2001","unstructured":"Short SC, Cook G, Flux G, Vini L, Harmer CL (2001) A phase II study using retinoids as redifferentiation agents to increase iodine uptake in metastatic thyroid cancers. Br J Cancer 85(Suppl 1): 102","journal-title":"Br J Cancer"},{"key":"BF6601072_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00259-001-0737-6","volume":"29","author":"D Simon","year":"2002","unstructured":"Simon D, Korber C, Krausch M, Segering J, Groth P, Gorges R, Grunwald F, Muller-Gartner HW, Schmutzler C, Kohrle J, Roher HD, Reiners C (2002) Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging 29: 775\u2013782","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"BF6601072_CR16","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1200\/JCO.2001.19.10.2616","volume":"19","author":"A Stojadinovic","year":"2001","unstructured":"Stojadinovic A, Ghossein RA, Hoos A, Urist MJ, Spiro RH, Shah JP, Brennan MF, Shaha AR, Singh B (2001) Hurthle cell carcinoma: a critical histopathologic appraisal. J Clin Oncol 19: 2616\u20132625","journal-title":"J Clin Oncol"},{"key":"BF6601072_CR17","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/sj.bjc.6690251","volume":"79","author":"LE Tisell","year":"1999","unstructured":"Tisell LE, Ahlman H, Wangberg B, Kolby L, Fjalling M, Forssell-Aronsson E, Molne J, Nilsson O (1999) Expression of somatostatin receptors in oncocytic (Hurthle cell) neoplasia of the thyroid. Br J Cancer 79: 1579\u20131582","journal-title":"Br J Cancer"},{"key":"BF6601072_CR18","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/snuc\/2002.31025","volume":"32","author":"R Valkema","year":"2002","unstructured":"Valkema R, De Jong M, Bakker WH, Breeman WA, Kooij PP, Lugtenburg PJ, De Jong FH, Christiansen A, Kam BL, De Herder WW, Stridsberg M, Lindemans J, Ensing G, Krenning EP (2002) Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience. Semin Nucl Med 32: 110\u2013122","journal-title":"Semin Nucl Med"},{"key":"BF6601072_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1089\/thy.1999.9.583","volume":"9","author":"N Valli","year":"1999","unstructured":"Valli N, Catargi B, Ronci N, Leccia F, Guyot M, Roger P, Ducassou D, Tabarin A (1999) Evaluation of indium-111 pentetreotide somato-statin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodine scintigraphy. Thyroid 9: 583\u2013589","journal-title":"Thyroid"},{"key":"BF6601072_CR20","first-page":"1288","volume":"8","author":"L Vini","year":"1998","unstructured":"Vini L, Fisher C, A'Hern R, Harmer C (1998) Hurthle cell cancer of the thyroid: the Royal Marsden experience. Thyroid 8: 1288","journal-title":"Thyroid"},{"key":"BF6601072_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/clon.2000.9196","volume":"12","author":"L Vini","year":"2000","unstructured":"Vini L, Harmer C (2000) Radioiodine treatment for differentiated thyroid cancer. Clin Oncol 12: 365\u2013372","journal-title":"Clin Oncol"},{"key":"BF6601072_CR22","first-page":"401","volume-title":"Treatment of Cancer","author":"L Vini","year":"2002","unstructured":"Vini L, Harmer C . (2002) Thyroid. In Treatment of Cancer, Price P, Sikora K (ed) pp 401\u2013427. London: Arnold"},{"key":"BF6601072_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1053\/snuc.2002.31565","volume":"32","author":"I Virgolini","year":"2002","unstructured":"Virgolini I, Britton K, Buscombe J, Moncayo R, Paganelli G, Riva P (2002) In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial. Semin Nucl Med 32: 148\u2013155","journal-title":"Semin Nucl Med"},{"key":"BF6601072_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/00006231-200106000-00011","volume":"22","author":"C Waldherr","year":"2001","unstructured":"Waldherr C, Schumacher T, Pless M, Crazzolara A, Maecke HR, Nitzsche EU, Haldemann A, Mueller-Brand J (2001) Radiopeptide transmitted internal irradiation of non-iodophil thyroid cancer and conventionally untreatable medullary thyroid cancer using. Nucl Med Commun 22: 673\u2013678","journal-title":"Nucl Med Commun"},{"key":"BF6601072_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s003300050779","volume":"9","author":"W Wiesner","year":"1999","unstructured":"Wiesner W, Engel H, von Schulthess GK, Krestin GP, Bicik I (1999) FDG PET-negative liver metastases of a malignant melanoma and FDG PET- positive hurthle cell tumor of the thyroid. Eur Radiol 9: 975\u2013978","journal-title":"Eur Radiol"},{"key":"BF6601072_CR26","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1177\/000348949810701006","volume":"107","author":"CJ Wilson","year":"1998","unstructured":"Wilson CJ, Woodroof JM, Girod DA (1998) First report of Hurthle cell carcinoma revealed by octreotide scanning. Ann Otol Rhinol Laryngol 107: 847\u2013850","journal-title":"Ann Otol Rhinol Laryngol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601072","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:50:52Z","timestamp":1684414252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["BF6601072"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601072","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}